160 related articles for article (PubMed ID: 21983493)
1. Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.
Bruno D; Pomara N; Nierenberg J; Ritchie JC; Lutz MW; Zetterberg H; Blennow K
Exp Gerontol; 2012 May; 47(5):347-52. PubMed ID: 21983493
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.
Bruno D; Nierenberg JJ; Ritchie JC; Lutz MW; Pomara N
Psychoneuroendocrinology; 2012 Mar; 37(3):366-71. PubMed ID: 21803501
[TBL] [Abstract][Full Text] [Related]
3. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.
Burggren AC; Mahmood Z; Harrison TM; Siddarth P; Miller KJ; Small GW; Merrill DA; Bookheimer SY
Alzheimers Dement; 2017 Jul; 13(7):739-748. PubMed ID: 28183529
[TBL] [Abstract][Full Text] [Related]
5. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
[TBL] [Abstract][Full Text] [Related]
6. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.
Bekris LM; Millard SP; Galloway NM; Vuletic S; Albers JJ; Li G; Galasko DR; DeCarli C; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Tsuang D; Peskind ER; Yu CE
J Alzheimers Dis; 2008 Apr; 13(3):255-66. PubMed ID: 18430993
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
8. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
[TBL] [Abstract][Full Text] [Related]
9. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
[TBL] [Abstract][Full Text] [Related]
11. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
Sjögren M; Blomberg M; Jonsson M; Wahlund LO; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
J Neurosci Res; 2001 Nov; 66(3):510-6. PubMed ID: 11746370
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Bos I; Vos S; Verhey F; Scheltens P; Teunissen C; Engelborghs S; Sleegers K; Frisoni G; Blin O; Richardson JC; Bordet R; Tsolaki M; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Lleó A; Johannsen P; Freund-Levi Y; Frölich L; Vandenberghe R; Westwood S; Dobricic V; Barkhof F; Legido-Quigley C; Bertram L; Lovestone S; Streffer J; Andreasson U; Blennow K; Zetterberg H; Visser PJ
Alzheimers Dement; 2019 May; 15(5):644-654. PubMed ID: 30853464
[TBL] [Abstract][Full Text] [Related]
13. Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25.
Butt OH; Long JM; Henson RL; Herries E; Sutphen CL; Fagan AM; Cruchaga C; Ladenson JH; Holtzman DM; Morris JC; Ances BM; Schindler SE;
Neurobiol Aging; 2021 Jun; 102():64-72. PubMed ID: 33765432
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
15. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
16. TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly.
Pomara N; Bruno D; Nierenberg JJ; Sidtis JJ; Martiniuk FT; Mehta PD; Zetterberg H; Blennow K
Neurochem Res; 2011 Jun; 36(6):1124-8. PubMed ID: 21455713
[TBL] [Abstract][Full Text] [Related]
17. Increased CSF cortisol in AD is a function of APOE genotype.
Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
[TBL] [Abstract][Full Text] [Related]
18. APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
Cardoso R; Lemos C; Oliveiros B; Almeida MR; Baldeiras I; Pereira CF; Santos A; Duro D; Vieira D; Santana I; Oliveira CR
J Alzheimers Dis; 2020; 78(2):587-601. PubMed ID: 33016906
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal modeling of cognitive aging and the TOMM40 effect.
Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
Meeker KL; Butt OH; Gordon BA; Fagan AM; Schindler SE; Morris JC; Benzinger TLS; Ances BM
Neurobiol Dis; 2022 May; 166():105662. PubMed ID: 35167933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]